Literature DB >> 9163866

Papillitis and vasculitis of the arteria spinalis anterior as complications of hepatitis C reinfection after liver transplantation.

T Propst1, A Propst, K Nachbauer, I Graziadei, H Willeit, R Margreiter, W Vogel.   

Abstract

It is well known that hepatitis C virus (HCV)-related chronic liver disease may be associated with various immunological disorders including mixed cryoglobulinemia, which is accompanied by cutaneous vasculitis, arthralgias, membrano-proliferative glomerulonephritis, and neuropathy in association with cryoprecipitable immune complexes in serum. We describe here the first case of central nervous system HCV infection with evidence of the virus in the cerebrospinal fluid in association with cryoglobulinemia in a patient who developed recurrent episodes of papillitis and vasculitis of the arteria spinalis anterior after liver transplantation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9163866     DOI: 10.1007/s001470050048

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  4 in total

Review 1.  Neurological complications of hepatitis C infection.

Authors:  Micheline McCarthy; Melissa R Ortega
Journal:  Curr Neurol Neurosci Rep       Date:  2012-12       Impact factor: 5.081

2.  Acute myelitis associated with HCV infection.

Authors:  Kentaro Suzuki; Masaki Takao; Yasuo Katayama; Ban Mihara
Journal:  BMJ Case Rep       Date:  2013-06-13

3.  A case of acute disseminated encephalomyelitis associated with hepatitis C virus infection.

Authors:  Jae Eun Sim; Jun-Bum Lee; Yu Na Cho; Sang Hyun Suh; Ja Kyung Kim; Kyung-Yul Lee
Journal:  Yonsei Med J       Date:  2012-07-01       Impact factor: 2.759

4.  Life-Threatening Cryoglobulinemic Patients With Hepatitis C: Clinical Description and Outcome of 279 Patients.

Authors:  Soledad Retamozo; Cándido Díaz-Lagares; Xavier Bosch; Albert Bové; Pilar Brito-Zerón; Maria-Eugenia Gómez; Jordi Yagüe; Xavier Forns; Maria C Cid; Manuel Ramos-Casals
Journal:  Medicine (Baltimore)       Date:  2013-09       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.